This content is for US investors only, if you are not a US investor please ignore this content. This content is a paid advertisement for BioStem Technologies, Inc from Sideways Frequency and Finimize. This is not Finimize editorial content. Finimize received a fixed fee from Sideways Frequency for producing, hosting and promoting this content via 4 email sends on behalf of BioStem Technologies, Inc, totalling $16,000. Other than the compensation received for this service, Finimize and its principals are not affiliated with either Sideways Frequency or BioStem Technologies, Inc. Finimize and its principals have no ownership in BioStem Technologies, Inc. The content on this page should not be taken as advice, an endorsement, or a recommendation from Finimize and its principals to buy or sell any security. Finimize and its principals have not evaluated the accuracy of any claims made on this page. Finimize and its principals recommend that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky and capital is at risk. Past performance is not indicative of future results. |